Cefacynar^®

Hard capsules

basic information

This product information corresponds to the patient leaflet, prescribed by law in Germany, in all essential parts.
 
Field of application:
dyspeptic complaints, especially in case of functional disorders of the derivating biliary tract. Note: in case of complaints persisting for more than 1 week or at periodic recurring or unclear complaints, a physician should be consulted.
 
Composition:
1 hard capsule contains:
Active ingredient:
dry extract from artichoke leaves (4-6:1) 400 mg.
Extraction solvent: water
 
Excipients:
talc, magnesium stearate, colloidal anhydrous silica, maize starch, lactose monohydrate, gelatin, purified water, sodium laurilsulfate, dyestuffs E141, E171, E172.
 
Contra-indications:
known allergy to artichoke and/or to other Compositae or to the excipients of the product. Biliary obstruction. Cefacynar® must not be taken by children under 12 years. In case of cholelithiasis, the remedy may only be used after consultation of a physician. There has not been sufficient research for the use of Cefacynar® during pregnancy and lactation. Therefore, it should not be used during pregnancy and lactation.
 
Interactions:
the simultaneous administration of Cefacynar® can weaken the efficacy of coagulationinhibiting substances of the coumarin type (phenprocoumon, warfarin).
Therefore, in case of simultaneous intake, the coagulation parameter should be monitored at close intervals especially at the beginning and after finalisation of the intake of Cefacynar®, in order to adjust the dosage of the coagulation-inhibiting medicaments. Patients taking Cefacynar® and simultaneously pharmaceuticals with one of these active ingredients should therefore consult their physician.
 
Precautions for use and warnings:
contains lactose.
 
Dosage:
adults and adolescents from 12 years take 1 hard capsule 3 times a day.
 
Kind and duration of application:
Cefacynar® hard capsules should be taken with the main meals with sufficient liquid (preferably a glass of water). In principle, the application of Cefacynar® is not limited, but is, however, determined by the course of the complaints. Please pay particular attention to "Precautions for use and warnings".
 
Undesirable effects:
with the application of artichoke-containing pharmaceuticals, cases of mild diarrhea with typically associated symptoms (e.g. abdominal cramping), epigastric complaints, nausea and heartburn as well as hypersensitivity reactions such as e.g. skin rashes have appeared.
Information on the frequency of these possible undesirable effects is not available. In the leaflet, the following is pointed out to the patient: in case you notice any of the above mentioned undesirable effects, inform your physician so that he/she can decide about the severity and possible necessary measures. With the first appearance of a hypersensitivity reaction, do not take in Cefacynar® again.
 
Commercial forms:
Hard capsules: 50 pcs., 100 pcs.
 
For any questions about risks and side effects please read the leaflet or ask your doctor or pharmacist.